QT IMAGING HOLDINGS, INC. current report, 21 September 2023

Full document

SEC Form 8-K Summary

Registrant: GigCapital5, Inc. (proposed name after closing: QT Imaging Holdings, Inc.)
Report date: September 21, 2023
Filing purpose: Disclosure of amendments to the proposed business combination with QT Imaging, Inc. and a related settlement agreement.

Business Context and Reporting Period

This filing does not report quarterly or annual operating results. It describes transaction developments involving GigCapital5, QT Imaging, and QTI Merger Sub, Inc. The proposed transaction would combine GigCapital5 and QT Imaging, with QT Imaging surviving as a wholly owned subsidiary and GigCapital5 being renamed QT Imaging Holdings, Inc.

Transaction Terms and Key Financial Matters

  • The Second Amendment to the Business Combination Agreement was executed on September 21, 2023.
  • The amendment removes the prior condition requiring GigCapital5 to have at least $15 million of cash at closing.
  • The amendment also removes the condition requiring GigCapital5 common stock to be listed on an exchange as of the closing date, although listing-related obligations and risks remain.
  • QT Imaging’s debt immediately before closing, after conversion of applicable convertible notes, must not exceed $4.8 million.
  • Converting notes are expected to convert into QT Imaging common stock immediately before closing. Other notes are expected to be amended and assumed by QTI Holdings as cash-pay obligations, generally without conversion rights.
  • The parties agreed to pursue a Yorkville standby equity purchase agreement. If completed, GigCapital5 would fund an initial pre-paid advance and issue Yorkville convertible promissory notes with principal amounts of $5.5 million and $4.5 million. The filing does not provide the final terms or confirm execution of the Yorkville SEPA.
  • The transaction includes a pool of 9 million potential earnout shares, subject to adjustment for specified corporate actions and release upon achievement of performance milestones.

Material Changes Versus Prior Disclosure

  • The closing timetable was extended, with the outside date moved to December 31, 2023.
  • Earnout measurement and release dates were revised to reflect the later anticipated closing.
  • Earnout milestones cover FDA clearance, system placements, revenue, clinical-quality images, clinical trial results, and stock-price performance.
  • The parties entered into a settlement agreement under which GigCapital5 intends to voluntarily dismiss its Delaware litigation against QT Imaging and its principal stockholder without prejudice.
  • The post-closing board is expected to have six initial directors, with an authorized seventh seat to be filled by an independent director and qualified key opinion leader.
  • GigCapital5 filed an extension proxy statement seeking to extend its business-combination period to December 31, 2023 without additional payments to the trust account. The stockholder meeting was scheduled for September 28, 2023.

Guidance, Outlook, Risks, and Contingencies

  • Closing remains subject to stockholder approvals, effectiveness of the registration statement, regulatory and other consents, exchange listing requirements, minimum net tangible assets of $5,000,001 after redemptions, debt and note-related actions, and other customary conditions.
  • The transaction may be terminated if it is not completed by December 31, 2023, if required approvals are not obtained, if legal restrictions arise, or if other specified breaches or closing failures occur.
  • Potential financing through the Yorkville SEPA is not assured and is identified as important to funding the transaction and QTI Holdings’ operating needs.
  • Key risks include substantial stockholder redemptions, insufficient financing, inability to maintain or obtain exchange listing, failure to obtain FDA clearances, delays in product commercialization, competition, execution and growth risks, legal proceedings, and failure to realize anticipated transaction benefits.
  • The earnout shares are contingent and may be cancelled if the applicable milestones become incapable of satisfaction. The filing does not provide current revenue, profit, cash-flow, margin, or liquidity figures for QT Imaging.

Investor Verification Checklist

  • Confirm whether the required stockholder approvals, registration statement effectiveness, and other closing conditions were ultimately satisfied.
  • Verify whether the Business Combination closed by December 31, 2023 and whether GigCapital5 completed the proposed name and corporate restructuring.
  • Review the final Yorkville SEPA, any pre-paid advance, note issuance, conversion terms, and resulting dilution.
  • Verify QT Imaging’s debt immediately before closing and the treatment of each outstanding convertible note and warrant.
  • Assess the number of shares subject to redemption, the cash remaining in the trust account, and post-redemption net tangible assets.
  • Review subsequent filings for FDA clearances, system placements, revenue performance, clinical milestones, and any earnout shares issued or cancelled.
  • Read the definitive proxy statement, registration statement, settlement agreement, and risk-factor disclosures for transaction-specific terms and conflicts of interest.